Expert Opinion on Therapeutic Targets

Papers
(The H4-Index of Expert Opinion on Therapeutic Targets is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma115
TRPA1 as a therapeutic target for nociceptive pain97
The cytokine storm of COVID-19: a spotlight on prevention and protection77
Esophageal cancer: emerging therapeutics52
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-249
New therapeutic targets in chronic kidney disease progression and renal fibrosis41
Aberrations of DNA repair pathways in prostate cancer: a cornerstone of precision oncology40
Glioblastoma multiforme: novel therapeutic targets38
Omentin-1: a newly discovered warrior against metabolic related diseases36
Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease36
Nutritional intervention in chronic pain: an innovative way of targeting central nervous system sensitization?35
The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma33
TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-233
CCR5 is a potential therapeutic target for cancer32
HSP47: a potential target for fibrotic diseases and implications for therapy30
Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain28
The role of microRNA in cisplatin resistance or sensitivity27
Targeting TANK-binding kinase 1 (TBK1) in cancer27
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy26
Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?24
Reversing T-cell exhaustion in immunotherapy: a review on current approaches and limitations24
MET alterations and their impact on the future of non-small cell lung cancer (NSCLC) targeted therapies23
Systemic lupus erythematosus (SLE): emerging therapeutic targets23
Microglia as therapeutic targets after neurological injury: strategy for cell therapy23
0.051403045654297